(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,5,6-trihydroxy-4-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Term ID

CHEBI:146613

Synonyms

WURCS=2.0/3,3,2/[h2112h_2*NCC/3=O_4*OSO/3=O/3=O][a2122A-1b_1-5][a2112h-1b_1-5_2*NCC/3=O_4*OSO/3=O/3=O]/1-2-3/a3-b1_b4-c1

Definition

References

GlyGen:G02086TB
GlyTouCan:G02086TB

Ontology

ChEBI ( EBI )

Relationships

is a type of: N-acyl-hexosamine

N-acyl-hexosamine Show first 5 Terms

Phenotype

Phenotype resulting from (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,5,6-trihydroxy-4-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Phenotype where environments contain (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,5,6-trihydroxy-4-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5R,6R)-3-Acetamido-4-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-2-yl]oxy-6-[(2S,3R,4S,5R)-2-acetamido-1,5,6-trihydroxy-4-sulfooxyhexan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid

Human Disease Model